Médecine autochtone sud-africaine (muti) et innovation biopharmaceutique : connaître l'umhlonyane

Authors

  • Julie Laplante Université d'Ottawa

Keywords:

Muti, Artemisia afra, South Africa, preclinical trial, biopharmaceutical innovation, ontology

Abstract

The medicinal plant umhlonyane or Artemisia afra
(Jaqu. Ex. Willd.) is currently under examination by the
preclinical trial in Cape Town, South Africa. The objective is
to determine its efficacy at the biomolecular level in order to
find a cure against the tuberculosis pandemic. In parallel, the
trial aims to recognize indigenous knowledge hinting at its
therapeutic potential. I thus aim to understand how scientists,
indigenous healer-diviners and herbalists collaborate and con
ciliate their respective approaches which distinguish them
selves in the ontologies they bring into being.

Downloads

Download data is not yet available.

Publication Facts

Metric
This article
Other articles
Peer reviewers 
0
2.4

Reviewer profiles  N/A

Author statements

Author statements
This article
Other articles
Data availability 
N/A
16%
External funding 
N/A
32%
Competing interests 
N/A
11%
Metric
This journal
Other journals
Articles accepted 
4%
33%
Days to publication 
2584
145

Indexed in

Editor & editorial board
profiles
Academic society 
Anthropologica
Publisher 
University of Victoria

Published

2014-04-30

How to Cite

Laplante, J. (2014). Médecine autochtone sud-africaine (muti) et innovation biopharmaceutique : connaître l’umhlonyane. Anthropologica, 56(1), 151–162. Retrieved from https://cas-sca.journals.uvic.ca/index.php/anthropologica/article/view/642